Whole paternal uniparental disomy of chromosome 4 with a novel homozygous IDUA splicing variant, c.159-9T>A, in a Chinese patient with mucopolysaccharidosis type I.


Journal

Molecular genetics & genomic medicine
ISSN: 2324-9269
Titre abrégé: Mol Genet Genomic Med
Pays: United States
ID NLM: 101603758

Informations de publication

Date de publication:
Aug 2024
Historique:
revised: 24 07 2024
received: 21 06 2024
accepted: 30 07 2024
medline: 12 8 2024
pubmed: 12 8 2024
entrez: 12 8 2024
Statut: ppublish

Résumé

Mucopolysaccharidosis type I (MPS-I) is a rare autosomal recessive genetic lysosomal storage disorder that is caused by pathogenic variants of the α-L-iduronidase (IDUA) gene. This study aimed to identify the genetic causes of MPS-I in a Chinese patient and construct a minigene of IDUA to analyze its variants upon splicing. Whole-exome sequencing (WES) and Sanger sequencing were used to confirm the potential causative variants. Single-nucleotide polymorphism (SNP) array was subsequently performed to confirm uniparental disomy (UPD). Minigene assay was performed to analyze the effect on splicing of mRNA. We meanwhile explored the conservative analysis and protein homology simulation. A novel homozygous splicing mutation of IDUA, c.159-9T>A, was identified in an individual presenting with overlapping features of MPS-I. Interestingly, only the father and sisters, but not the mother, carried the variant in a heterozygous state. WES and SNP array analyses validated paternal UPD on chromosome 4. Minigene splicing revealed two aberrant splicing events: exon 2 skipping and intron 1 retention. Moreover, the specific structure of the mutant protein obviously changed according to the results of the homologous model. This study describes a rare autosomal recessive disorder with paternal UPD of chromosome 4 leading to the homozygosity of the IDUA splicing variant in patients with MPS-I for the first time. This study expands the variant spectrum of IDUA and provides insights into the splicing system, facilitating its enhanced diagnosis and treatment.

Sections du résumé

BACKGROUND BACKGROUND
Mucopolysaccharidosis type I (MPS-I) is a rare autosomal recessive genetic lysosomal storage disorder that is caused by pathogenic variants of the α-L-iduronidase (IDUA) gene. This study aimed to identify the genetic causes of MPS-I in a Chinese patient and construct a minigene of IDUA to analyze its variants upon splicing.
METHODS METHODS
Whole-exome sequencing (WES) and Sanger sequencing were used to confirm the potential causative variants. Single-nucleotide polymorphism (SNP) array was subsequently performed to confirm uniparental disomy (UPD). Minigene assay was performed to analyze the effect on splicing of mRNA. We meanwhile explored the conservative analysis and protein homology simulation.
RESULTS RESULTS
A novel homozygous splicing mutation of IDUA, c.159-9T>A, was identified in an individual presenting with overlapping features of MPS-I. Interestingly, only the father and sisters, but not the mother, carried the variant in a heterozygous state. WES and SNP array analyses validated paternal UPD on chromosome 4. Minigene splicing revealed two aberrant splicing events: exon 2 skipping and intron 1 retention. Moreover, the specific structure of the mutant protein obviously changed according to the results of the homologous model.
CONCLUSIONS CONCLUSIONS
This study describes a rare autosomal recessive disorder with paternal UPD of chromosome 4 leading to the homozygosity of the IDUA splicing variant in patients with MPS-I for the first time. This study expands the variant spectrum of IDUA and provides insights into the splicing system, facilitating its enhanced diagnosis and treatment.

Identifiants

pubmed: 39132856
doi: 10.1002/mgg3.2507
doi:

Substances chimiques

Iduronidase EC 3.2.1.76
IDUA protein, human EC 3.2.1.76

Types de publication

Journal Article Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2507

Subventions

Organisme : Science and Technology Development Program of Ningbo
ID : 2022S035
Organisme : Innovation Project of Distinguished Medical Team in Ningbo
ID : 2022020405
Organisme : Ningbo Medical and Health Brand Discipline
ID : PPXK2024-06
Organisme : Ningbo Science and Technology Project
ID : 2023Z178

Informations de copyright

© 2024 The Author(s). Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.

Références

Aminoff, A., Gunnar, E., Barbaro, M., Mannila, M. N., Duponchel, C., Tosi, M., Robinson, K. L., Hernell, O., & Ehrenborg, E. (2012). Novel mutations in microsomal triglyceride transfer protein including maternal uniparental disomy in two patients with abetalipoproteinemia. Clinical Genetics, 82, 197–200. https://doi.org/10.1111/j.1399‐0004.2011.01828.x
Beck, M., Arn, P., Giugliani, R., Muenzer, J., Okuyama, T., Taylor, J., & Fallet, S. (2014). The natural history of MPS I: Global perspectives from the MPS I registry. Genetics in Medicine, 16, 759–765. https://doi.org/10.1038/gim.2014.25
Bie, H., Yin, J., He, X., Kermode, A. R., Goddard‐Borger, E. D., Withers, S. G., & James, M. N. G. (2013). Insights into mucopolysaccharidosis I from the structure and action of alpha‐L‐iduronidase. Nature Chemical Biology, 9, 739–745. https://doi.org/10.1038/nchembio.1357
Chen, M., Hao, H., Xiong, H., Cai, Y., Ma, F., Shi, C., Xiao, X., & Li, S. (2020). Segmental uniparental disomy of chromosome 4 in a patient with methylmalonic acidemia. Molecular Genetics & Genomic Medicine, 8, e1063. https://doi.org/10.1002/mgg3.1063
Clarke, L. A., Giugliani, R., Guffon, N., Jones, S. A., Keenan, H. A., Munoz‐Rojas, M. V., Okuyama, T., Viskochil, D., Whitley, C. B., Wijburg, F. A., & Muenzer, J. (2019). Genotype‐phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the international MPS I registry. Clinical Genetics, 96, 281–289. https://doi.org/10.1111/cge.13583
Cottrell, C. E., Mendell, J., Hart‐Kothari, M., Ell, D., Thrush, D. L., Astbury, C., Pastore, M., Gastier‐Foster, J. M., & Pyatt, R. E. (2012). Maternal uniparental disomy of chromosome 4 in a patient with limb‐girdle muscular dystrophy 2E confirmed by SNP array technology. Clinical Genetics, 81, 578–583. https://doi.org/10.1111/j.1399‐0004.2011.01681.x
Ding, Q., Ouyang, Q., Xi, X., Wang, X., Shen, Y., & Wang, H. (2012). Maternal chromosome 4 heterodisomy/isodisomy and Bbeta chain Trp323X mutation resulting in severe hypodysfibrinogenaemia. Thrombosis and Haemostasis, 108, 654–661. https://doi.org/10.1160/TH12‐02‐0088
Fromer, M., & Purcell, S. M. (2014). Using XHMM software to detect copy number variation in whole‐exome sequencing data. Current Protocols in Human Genetics, 81, 7–23. https://doi.org/10.1002/0471142905.hg0723s81
Giugliani, R., Muschol, N., Keenan, H. A., Dant, M., & Muenzer, J. (2021). Improvement in time to treatment, but not time to diagnosis, in patients with mucopolysaccharidosis type I. Archives of Disease in Childhood, 106, 674–679. https://doi.org/10.1136/archdischild‐2020‐319040
Hampe, C. S., Eisengart, J. B., Lund, T. C., Orchard, P. J., Swietlicka, M., Wesley, J., & McIvor, R. S. (2020). Mucopolysaccharidosis type I: A review of the natural history and molecular pathology. Cells‐Basel, 9, 1838. https://doi.org/10.3390/cells9081838
Hampe, C. S., Wesley, J., Lund, T. C., Orchard, P. J., Polgreen, L. E., Eisengart, J. B., McLoon, L. K., Cureoglu, S., Schachern, P., & McIvor, R. S. (2021). Mucopolysaccharidosis type I: Current treatments, limitations, and prospects for improvement. Biomolecules, 11, 189. https://doi.org/10.3390/biom11020189
Katja, K., Inga, V., Ramona, L., Almuth, C., & Maria, M. N. (2020). Mucopolysaccharidosis type I due to maternal uniparental disomy of chromosome 4 with partial isodisomy of 4p16.3p15.2. Molecular Genetics and Metabolism Reports, 25, 100660. https://doi.org/10.1016/j.ymgmr.2020.100660
Labrijn‐Marks, I., Somers‐Bolman, G. M., In, T. G. S., Hoogeveen‐Westerveld, M., Kroos, M. A., Ala‐Mello, S., Amaral, O., Miranda, C. S., Mavridou, I., Michelakakis, H., Naess, K., Verheijen, F. W., Hoefsloot, L. H., Dijkhuizen, T., Benjamins, M., van den Hout, H. J. M., van der Ploeg, A. T., Pijnappel, W. W. M. P., Saris, J. J., & Halley, D. J. (2019). Segmental and total uniparental isodisomy (UPiD) as a disease mechanism in autosomal recessive lysosomal disorders: Evidence from SNP arrays. European Journal of Human Genetics, 27, 919–927. https://doi.org/10.1038/s41431‐019‐0348‐y
Liu, W., Zhang, H., Wang, J., Yu, G., Qiu, W., Li, Z., Chen, M., Choy, K. W., & Sun, X. F. (2015). Prenatal diagnosis of complete maternal uniparental isodisomy of chromosome 4 in a fetus without congenital abnormality or inherited disease‐associated variations. Molecular Cytogenetics, 8, 85. https://doi.org/10.1186/s13039‐015‐0190‐z
Losekoot, M., Ruivenkamp, C. A., Tholens, A. P., Grimbergen, J. E., Vijfhuizen, L., Vermeer, S., Dijkman, H. B., Cornelissen, E. A., Bongers, E. M., & Peters, D. J. (2012). Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for a PKD2 missense mutation due to uniparental disomy. Journal of Medical Genetics, 49, 37–40. https://doi.org/10.1136/jmedgenet‐2011‐100452
Middleton, F. A., Trauzzi, M. G., Shrimpton, A. E., Gentile, K. L., Morley, C. P., Medeiros, H., Pato, M. T., & Pato, C. N. (2006). Complete maternal uniparental isodisomy of chromosome 4 in a subject with major depressive disorder detected by high density SNP genotyping arrays. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 141B, 28–32. https://doi.org/10.1002/ajmg.b.30250
Nagpal, R., Goyal, R. B., Priyadarshini, K., Kashyap, S., Sharma, M., Sinha, R., & Sharma, N. (2022). Mucopolysaccharidosis: A broad review. Indian Journal of Ophthalmology, 70, 2249–2261. https://doi.org/10.4103/ijo.IJO_425_22
Nakka, P., Pattillo, S. S., O'Donnell‐Luria, A. H., McManus, K. F., 23andMe Research Team, Mountain, J. L., Ramachandran, S., & Sathirapongsasuti, J. F. (2019). Characterization of prevalence and health consequences of uniparental Disomy in four million individuals from the general population. American Journal of Human Genetics, 105, 921–932. https://doi.org/10.1016/j.ajhg.2019.09.016
Palumbo, P., Palumbo, O., Leone, M. P., Stallone, R., Palladino, T., Zelante, L., & Carella, M. (2015). Maternal uniparental isodisomy (iUPD) of chromosome 4 in a subject with mild intellectual disability and speech delay. American Journal of Medical Genetics. Part A, 167A, 2219–2222. https://doi.org/10.1002/ajmg.a.37142
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier‐Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., Rehm, H. L., & ACMG Laboratory Quality Assurance Committee. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17, 405–424. https://doi.org/10.1038/gim.2015.30
Riggs, E. R., Andersen, E. F., Cherry, A. M., Kantarci, S., Kearney, H., Patel, A., Raca, G., Ritter, D. I., South, S. T., Thorland, E. C., Pineda‐Alvarez, D., Aradhya, S., & Martin, C. L. (2020). Technical standards for the interpretation and reporting of constitutional copy‐number variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the clinical genome resource (ClinGen). Genetics in Medicine, 22, 245–257. https://doi.org/10.1038/s41436‐019‐0686‐8
Roca, I., Gonzalez‐Castro, L., Fernandez, H., Couce, M. L., & Fernandez‐Marmiesse, A. (2019). Free‐access copy‐number variant detection tools for targeted next‐generation sequencing data. Mutation Research, Reviews in Mutation Research, 779, 114–125. https://doi.org/10.1016/j.mrrev.2019.02.005
Scott, H. S., Guo, X. H., Hopwood, J. J., & Morris, C. P. (1992). Structure and sequence of the human alpha‐L‐iduronidase gene. Genomics, 13, 1311–1313. https://doi.org/10.1016/0888‐7543(92)90053‐u
Soler‐Palacin, P., Garcia‐Prat, M., Martin‐Nalda, A., Franco‐Jarava, C., Riviere, J. G., Plaja, A., Bezdan, D., Bosio, M., Martínez‐Gallo, M., Ossowski, S., & Colobran, R. (2018). LRBA deficiency in a patient with a novel homozygous mutation due to chromosome 4 segmental uniparental isodisomy. Frontiers in Immunology, 9, 2397. https://doi.org/10.3389/fimmu.2018.02397
Spena, S., Duga, S., Asselta, R., Peyvandi, F., Mahasandana, C., Malcovati, M., & Tenchini, M. L. (2004). Congenital afibrinogenaemia caused by uniparental isodisomy of chromosome 4 containing a novel 15‐kb deletion involving fibrinogen Aalpha‐chain gene. European Journal of Human Genetics, 12, 891–898. https://doi.org/10.1038/sj.ejhg.5201207
Tachibana, N., Hosono, K., Nomura, S., Arai, S., Torii, K., Kurata, K., Sato, M., Shimakawa, S., Azuma, N., Ogata, T., Wada, Y., Okamoto, N., Saitsu, H., Nishina, S., & Hotta, Y. (2022). Maternal uniparental isodisomy of chromosome 4 and 8 in patients with retinal dystrophy: SRD5A3‐congenital disorders of glycosylation and RP1‐related retinitis pigmentosa. Genes (Basel), 13, 359. https://doi.org/10.3390/genes13020359
Terlato, N. J., & Cox, G. F. (2003). Can mucopolysaccharidosis type I disease severity be predicted based on a patient's genotype? A comprehensive review of the literature. Genetics in Medicine, 5, 286–294. https://doi.org/10.1097/01.GIM.0000078027.83236.49
Yang, X. P., Inazu, A., Yagi, K., Kajinami, K., Koizumi, J., & Mabuchi, H. (1999). Abetalipoproteinemia caused by maternal isodisomy of chromosome 4q containing an intron 9 splice acceptor mutation in the microsomal triglyceride transfer protein gene. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 1950–1955. https://doi.org/10.1161/01.atv.19.8.1950

Auteurs

Lulu Yan (L)

The Central Laboratory of Birth Defects Prevention and Control, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, China.

Shuxia Ding (S)

Department of Pediatrics, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, China.

Yan He (Y)

Department of Pediatrics, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, China.

Bin Fu (B)

Health Science Center, Ningbo University, Ningbo, Zhejiang, China.

Changshui Chen (C)

Ningbo Key Laboratory for the Prevention and Treatment of Embryogenic Diseases, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, China.

Haibo Li (H)

The Central Laboratory of Birth Defects Prevention and Control, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo, Zhejiang, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH